MLA
MRK icon

MB, Levis & Associates’s Merck MRK Stock Holding History

MB, Levis & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
11,732
-40
-0.3% -$4.68K 0.56% 33
2026
Q1 		$1.42M Sell
11,772
-319
-3% -$36.8K 0.59% 32
2025
Q4 		$1.27M Sell
12,091
-379
-3% -$35.6K 0.54% 32
2025
Q3 		$1.05M Sell
12,470
-1,562
-11% -$129K 0.45% 32
2025
Q2 		$1.11M Buy
14,032
+403
+3% +$32K 0.49% 34
2025
Q1 		$1.22M Buy
13,629
+101
+0.7% +$9.43K 0.57% 32
2024
Q4 		$1.35M Buy
13,528
+75
+0.6% +$7.73K 0.67% 27
2024
Q3 		$1.53M Buy
13,453
+31
+0.2% +$3.68K 0.75% 23
2024
Q2 		$1.66M Buy
13,422
+20
+0.1% +$2.58K 0.87% 22
2024
Q1 		$1.77M Buy
13,402
+42
+0.3% +$5.18K 0.95% 22
2023
Q4 		$1.46M Buy
13,360
+98
+0.7% +$10.2K 0.83% 22
2023
Q3 		$1.37M Sell
13,262
-72
-0.5% -$7.76K 0.89% 22
2023
Q2 		$1.54M Buy
13,334
+39
+0.3% +$4.43K 0.99% 21
2023
Q1 		$1.41M Sell
13,295
-47
-0.4% -$5.07K 0.98% 22
2022
Q4 		$1.48M Buy
+13,342
New +$1.36M 1.16% 21

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

MB, Levis & Associates's MRK Position: Q2 2026 in Review

MB, Levis & Associates reduced its Merck (MRK) stake by 0.34% in Q2 2026, selling an estimated $4.68K and leaving 11,732 shares worth $1.51M. The position accounts for 0.56% of the portfolio, ranked #33.

MB, Levis & Associates first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.77M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MB, Levis & Associates held 11,732 shares of Merck worth $1.51M as of Q2 2026.
  • MB, Levis & Associates sold 40 Merck shares in Q2 2026, an estimated $4.68K.
  • Merck made up 0.56% of MB, Levis & Associates's portfolio in Q2 2026, its #33 holding.
  • MB, Levis & Associates first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Merck position peaked at $1.77M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.